• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SWI/SNF 染色质重塑复合物在胰腺导管腺癌中的作用。

The role of the SWI/SNF chromatin remodeling complex in pancreatic ductal adenocarcinoma.

机构信息

Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka-sayama City, Japan.

出版信息

Cancer Sci. 2021 Feb;112(2):490-497. doi: 10.1111/cas.14768. Epub 2020 Dec 28.

DOI:10.1111/cas.14768
PMID:33301642
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7894000/
Abstract

ATP-dependent chromatin remodeling complexes are a group of epigenetic regulators that can alter the assembly of nucleosomes and regulate the accessibility of transcription factors to DNA in order to modulate gene expression. One of these complexes, the SWI/SNF chromatin remodeling complex is mutated in more than 20% of human cancers. We have investigated the roles of the SWI/SNF complex in pancreatic ductal adenocarcinoma (PDA), which is the most lethal type of cancer. Here, we reviewed the recent literature regarding the role of the SWI/SNF complex in pancreatic tumorigenesis and current knowledge about therapeutic strategies targeting the SWI/SNF complex in PDA. The subunits of the SWI/SNF complex are mutated in 14% of human PDA. Recent studies have shown that they have context-dependent oncogenic or tumor-suppressive roles in pancreatic carcinogenesis. To target its tumor-suppressive properties, synthetic lethal strategies have recently been developed. In addition, their oncogenic properties could be novel therapeutic targets. The SWI/SNF subunits are potential therapeutic targets for PDA, and further understanding of the precise role of the SWI/SNF complex subunits in PDA is required for further development of novel strategies targeting SWI/SNF subunits against PDA.

摘要

ATP 依赖的染色质重塑复合物是一组表观遗传调节剂,能够改变核小体的组装,并调节转录因子与 DNA 的可及性,从而调节基因表达。这些复合物之一,SWI/SNF 染色质重塑复合物在超过 20%的人类癌症中发生突变。我们研究了 SWI/SNF 复合物在胰腺导管腺癌 (PDA) 中的作用,这是最致命的癌症类型。在这里,我们回顾了关于 SWI/SNF 复合物在胰腺肿瘤发生中的作用的最新文献,以及针对 PDA 中 SWI/SNF 复合物的治疗策略的现有知识。SWI/SNF 复合物的亚基在 14%的人类 PDA 中发生突变。最近的研究表明,它们在胰腺发生癌变中具有上下文相关的致癌或肿瘤抑制作用。为了靶向其肿瘤抑制特性,最近开发了合成致死策略。此外,它们的致癌特性可能是新的治疗靶点。SWI/SNF 亚基是 PDA 的潜在治疗靶点,为了进一步开发针对 PDA 的 SWI/SNF 亚基的新型策略,需要进一步了解 SWI/SNF 复合物亚基在 PDA 中的精确作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d07f/7894000/42f76217abba/CAS-112-490-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d07f/7894000/a342b646b9ed/CAS-112-490-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d07f/7894000/8a048789ca6e/CAS-112-490-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d07f/7894000/05a1723ff336/CAS-112-490-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d07f/7894000/42f76217abba/CAS-112-490-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d07f/7894000/a342b646b9ed/CAS-112-490-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d07f/7894000/8a048789ca6e/CAS-112-490-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d07f/7894000/05a1723ff336/CAS-112-490-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d07f/7894000/42f76217abba/CAS-112-490-g004.jpg

相似文献

1
The role of the SWI/SNF chromatin remodeling complex in pancreatic ductal adenocarcinoma.SWI/SNF 染色质重塑复合物在胰腺导管腺癌中的作用。
Cancer Sci. 2021 Feb;112(2):490-497. doi: 10.1111/cas.14768. Epub 2020 Dec 28.
2
BAFfling pathologies: Alterations of BAF complexes in cancer.BAF 相关病变:癌症中 BAF 复合物的改变。
Cancer Lett. 2018 Apr 10;419:266-279. doi: 10.1016/j.canlet.2018.01.046. Epub 2018 Jan 31.
3
Advances in the role of SWI/SNF complexes in tumours.SWI/SNF 复合物在肿瘤中的作用研究进展。
J Cell Mol Med. 2023 Apr;27(8):1023-1031. doi: 10.1111/jcmm.17709. Epub 2023 Mar 8.
4
Recent insights into the SWI/SNF complex and the molecular mechanism of hSNF5 deficiency in rhabdoid tumors.近期对 SWI/SNF 复合物的深入了解,以及横纹肌肉瘤中 hSNF5 缺失的分子机制。
Cancer Med. 2023 Aug;12(15):16323-16336. doi: 10.1002/cam4.6255. Epub 2023 Jun 14.
5
Convergent structural alterations define SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeler as a central tumor suppressive complex in pancreatic cancer.汇聚的结构改变将 SWItch/Sucrose NonFermentable(SWI/SNF)染色质重塑因子定义为胰腺癌中一个核心的肿瘤抑制复合物。
Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):E252-9. doi: 10.1073/pnas.1114817109. Epub 2012 Jan 10.
6
Composition and Function of Mutant Swi/Snf Complexes.突变型Swi/Snf复合物的组成与功能
Cell Rep. 2017 Feb 28;18(9):2124-2134. doi: 10.1016/j.celrep.2017.01.058.
7
The SWI/SNF ATP-Dependent Chromatin Remodeling Complex in Arabidopsis Responds to Environmental Changes in Temperature-Dependent Manner.拟南芥中 SWI/SNF ATP 依赖的染色质重塑复合物以温度依赖的方式响应环境变化。
Int J Mol Sci. 2020 Jan 23;21(3):762. doi: 10.3390/ijms21030762.
8
SWI/SNF chromatin remodeling and human malignancies.SWI/SNF 染色质重塑与人类恶性肿瘤。
Annu Rev Pathol. 2015;10:145-71. doi: 10.1146/annurev-pathol-012414-040445. Epub 2014 Oct 27.
9
Chromatin remodellers as therapeutic targets.染色质重塑因子作为治疗靶点。
Nat Rev Drug Discov. 2024 Sep;23(9):661-681. doi: 10.1038/s41573-024-00978-5. Epub 2024 Jul 16.
10
SMARCC2 silencing suppresses oncogenic activation through modulation of chromatin accessibility in breast cancer.SMARCC2 沉默通过调节乳腺癌染色质可及性抑制致癌激活。
Biochem Biophys Res Commun. 2024 Sep 10;724:150223. doi: 10.1016/j.bbrc.2024.150223. Epub 2024 Jun 4.

引用本文的文献

1
SWI/SNF Complex-Deficient Undifferentiated Carcinoma of the Pancreas: Clinicopathologic and Genomic Analysis.SWI/SNF 复合物缺陷型胰腺未分化癌:临床病理和基因组分析。
Mod Pathol. 2024 Nov;37(11):100585. doi: 10.1016/j.modpat.2024.100585. Epub 2024 Jul 31.
2
FBXO28 promotes proliferation, invasion, and metastasis of pancreatic cancer cells through regulation of SMARCC2 ubiquitination.FBXO28 通过调控 SMARCC2 的泛素化促进胰腺癌细胞的增殖、侵袭和转移。
Aging (Albany NY). 2023 Jun 21;15(12):5381-5398. doi: 10.18632/aging.204780.
3
Mutual Regulation of ncRNAs and Chromatin Remodeling Complexes in Normal and Pathological Conditions.

本文引用的文献

1
Synthetic lethal therapy based on targeting the vulnerability of SWI/SNF chromatin remodeling complex-deficient cancers.基于靶向 SWI/SNF 染色质重塑复合物缺陷型癌症脆弱性的合成致死疗法。
Cancer Sci. 2020 Mar;111(3):774-782. doi: 10.1111/cas.14311. Epub 2020 Feb 22.
2
Renal medullary carcinomas depend upon loss and are sensitive to proteasome inhibition.肾髓质癌依赖于这种丢失,并对蛋白酶体抑制敏感。
Elife. 2019 Mar 12;8:e44161. doi: 10.7554/eLife.44161.
3
MDM2 and MDM4 Are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors.
非编码 RNA 与染色质重塑复合物在正常和病理条件下的相互调控。
Int J Mol Sci. 2023 Apr 25;24(9):7848. doi: 10.3390/ijms24097848.
4
SWI/SNF complex, promising target in melanoma therapy: Snapshot view.SWI/SNF复合物,黑色素瘤治疗中有前景的靶点:简要概述。
Front Med (Lausanne). 2023 Feb 9;10:1096615. doi: 10.3389/fmed.2023.1096615. eCollection 2023.
5
Epigenetics in Pancreatic Ductal Adenocarcinoma: Impact on Biology and Utilization in Diagnostics and Treatment.胰腺导管腺癌中的表观遗传学:对生物学的影响及其在诊断和治疗中的应用
Cancers (Basel). 2022 Nov 30;14(23):5926. doi: 10.3390/cancers14235926.
6
The Role of Epigenetic Modifications in Human Cancers and the Use of Natural Compounds as Epidrugs: Mechanistic Pathways and Pharmacodynamic Actions.表观遗传学修饰在人类癌症中的作用以及天然化合物作为内源性药物的应用:作用机制和药效学作用。
Biomolecules. 2022 Feb 25;12(3):367. doi: 10.3390/biom12030367.
7
Liquid Biopsy as a Prognostic and Theranostic Tool for the Management of Pancreatic Ductal Adenocarcinoma.液体活检作为胰腺导管腺癌管理的预后和治疗诊断工具
Front Med (Lausanne). 2022 Jan 14;8:788869. doi: 10.3389/fmed.2021.788869. eCollection 2021.
8
Novel Compounds for Targeted Degradation of BRD9 and Their Use for Treating Cancer.用于靶向降解BRD9的新型化合物及其在治疗癌症中的应用。
ACS Med Chem Lett. 2021 Dec 8;13(1):17-18. doi: 10.1021/acsmedchemlett.1c00658. eCollection 2022 Jan 13.
9
BRD9 Bifunctional Degraders for Treating Cancer.用于治疗癌症的BRD9双功能降解剂
ACS Med Chem Lett. 2021 Nov 6;12(12):1879-1880. doi: 10.1021/acsmedchemlett.1c00580. eCollection 2021 Dec 9.
10
Integration of Epigenetic Mechanisms into Non-Genotoxic Carcinogenicity Hazard Assessment: Focus on DNA Methylation and Histone Modifications.将表观遗传机制纳入非遗传毒性致癌性危害评估中:重点关注 DNA 甲基化和组蛋白修饰。
Int J Mol Sci. 2021 Oct 11;22(20):10969. doi: 10.3390/ijms222010969.
MDM2 和 MDM4 是恶性横纹肌样瘤的治疗靶点。
Cancer Res. 2019 May 1;79(9):2404-2414. doi: 10.1158/0008-5472.CAN-18-3066. Epub 2019 Feb 12.
4
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary.CDK4/6 抑制剂针对 SMARCA4 决定的 cyclin D1 缺陷,靶向治疗高钙血症型卵巢小细胞癌。
Nat Commun. 2019 Feb 4;10(1):558. doi: 10.1038/s41467-018-06958-9.
5
SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancer.SMARCA4 缺失与 CDK4/6 抑制在非小细胞肺癌中具有合成致死性。
Nat Commun. 2019 Feb 4;10(1):557. doi: 10.1038/s41467-019-08380-1.
6
Targeting the Vulnerability of Glutathione Metabolism in ARID1A-Deficient Cancers.靶向 ARID1A 缺陷型癌症中谷胱甘肽代谢的脆弱性。
Cancer Cell. 2019 Feb 11;35(2):177-190.e8. doi: 10.1016/j.ccell.2018.12.009. Epub 2019 Jan 24.
7
Cancer statistics, 2019.癌症统计数据,2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
8
A non-canonical SWI/SNF complex is a synthetic lethal target in cancers driven by BAF complex perturbation.非典型 SWI/SNF 复合物是由 BAF 复合物扰动驱动的癌症的合成致死靶点。
Nat Cell Biol. 2018 Dec;20(12):1410-1420. doi: 10.1038/s41556-018-0221-1. Epub 2018 Nov 5.
9
The chromatin accessibility landscape of primary human cancers.原发性人类癌症的染色质可及性图谱。
Science. 2018 Oct 26;362(6413). doi: 10.1126/science.aav1898.
10
Modular Organization and Assembly of SWI/SNF Family Chromatin Remodeling Complexes.SWI/SNF 家族染色质重塑复合物的模块化组织与组装。
Cell. 2018 Nov 15;175(5):1272-1288.e20. doi: 10.1016/j.cell.2018.09.032. Epub 2018 Oct 18.